Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 27;23(9):4809.
doi: 10.3390/ijms23094809.

Can Selenium Reduce the Susceptibility and Severity of SARS-CoV-2?-A Comprehensive Review

Affiliations
Review

Can Selenium Reduce the Susceptibility and Severity of SARS-CoV-2?-A Comprehensive Review

Muhammed Majeed et al. Int J Mol Sci. .

Abstract

The SARS-CoV-2 infection is a highly contagious viral infection, which has claimed millions of lives in the last two years. The infection can cause acute respiratory distress, myocarditis, and systemic inflammatory response in severe cases. The interaction of the viral spike protein with the angiotensin-converting enzyme in various tissues causes damage to vital organs and tissues, leading to complications in the post-infection period. Vaccines and antiviral drugs have improved patient response to the infection, but the long-term effect on vital organs is still unknown. Investigations are now focused on supportive nutrient therapies, which can mitigate the susceptibility as well as the long-term complications of COVID-19. Selenium is one such micronutrient that plays a vital role in preventing oxidative stress induced by the virus. Further, selenium is important for effective immune response, controlling systemic inflammation, and maintain overall health of humans. We examine the role of selenium in various aspects of SARS-CoV-2 infection and address the importance of selenium supplementation in reducing the susceptibility and severity of infection in this review.

Keywords: SARS-CoV-2; immunity; inflammation; micronutrient; oxidative stress; selenium.

PubMed Disclaimer

Conflict of interest statement

All the authors are employees of Sami-Sabinsa group Limited or Sabinsa Corporation, which both sell selenium-based supplements. The company had no role in the design, collection, analyses, or interpretation of data, the writing of the manuscript, or the decision to publish the results.

Figures

Figure 1
Figure 1
Multiple risk factors of severe coronavirus disease 2019 (COVID-19) illness.
Figure 2
Figure 2
Mechanism of SARS-CoV-2 infection via the interaction with angiotensin-converting enzyme 2 (ACE2) receptors. TMPRSS2: Transmembrane protease, serine 2. The arrows represent the sequence of events following SARS-CoV-2 infection.
Figure 3
Figure 3
Selenoproteins in viral infection: Dietary selenium is incorporated in selenoproteins that play regulatory roles in immune function and redox homeostasis. These include the Selenoproteins glutathione peroxidases (GPX), 15 kDa selenoprotein F (SELENOF), selenoproteins K and S and thioredoxin reductases (TXNRD). Viral infection alters the expression of selenoproteins and induces oxidative stress, increasing virus virulence. The resultant inflammation and excess cytokine production eventually lead to poor clinical outcomes. The blue arrows represent the sequence of events of selenoprotein synthesis from dietary selenium. The red arrows represent the consequence of viral infection. Adequate selenium levels can reduce the impact of viral infection and help in an optimum antiviral response.
Figure 4
Figure 4
Effects of selenium supplementation on COVID-19. Adequate selenium levels reduce oxidative stress by restoring antioxidant enzymes, reduce cell death and coagulation pathways, and protect endothelial cells, thus having an overall protective effect on lungs and other organs.

Similar articles

Cited by

References

    1. Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., et al. The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5:536–544. doi: 10.1038/s41564-020-0695-z. - DOI - PMC - PubMed
    1. World Health Organization (WHO) Coronavirus Disease (COVID-19) Pandemic. [(accessed on 20 April 2022)]. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
    1. Ejaz H., Alsrhani A., Zafar A., Javed H., Junaid K., Abdalla A.E., Abosalif K.O.A., Ahmed Z., Younas S. COVID-19 and comorbidities: Deleterious impact on infected patients. J. Infect. Public Health. 2020;13:1833–1839. doi: 10.1016/j.jiph.2020.07.014. - DOI - PMC - PubMed
    1. Pan L., Mu M., Yang P., Sun Y., Wang R., Yan J., Li P., Hu B., Wang J., Hu C., et al. Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. Am. J. Gastroenterol. 2020;115:766–773. doi: 10.14309/ajg.0000000000000620. - DOI - PMC - PubMed
    1. Guo Y.-R., Cao Q.-D., Hong Z.-S., Tan Y.-Y., Chen S.-D., Jin H.-J., Tan K.-S., Wang D.-Y., Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—An update on the status. Mil. Med. Res. 2020;7:11. doi: 10.1186/s40779-020-00240-0. - DOI - PMC - PubMed

LinkOut - more resources